A new set of recommendations has been developed for evaluating cost-effectiveness in health and medicine, according to a report published in the September 13 issue of the Journal of the American Medical Association.
[Photo: Dr. Anirban Basu]
Dr. Anirban Basu, professor of health services at the University of Washington School of Public Health, was on the expert panel that reviewed the current status of cost-effectiveness analysis and updated guidelines presented by the 1996 Panel on Cost-Effectiveness in Health and Medicine, convened by the U.S. Public Health Service.
“These methods and guidelines are both important and timely given the increase in health care costs,” said Dr. Basu, who is also a professor of pharmacy and adjunct professor of economics at the UW.
Members of the Second Panel on Cost-Effectiveness in Health and Medicine, including Dr. Basu, developed the recommendations by consensus over three-and-a-half years. The recommendations were analyzed by external reviewers and through a public posting process.
Among the panel’s recommendations:
Dr. Basu said the guidelines are not intended to promote the rationing of health care but rather to shed light on the most cost-effective interventions so policies can be enacted to promote them.
The second panel was primarily funded by grants from the Agency for Healthcare Research and Quality, Robert Wood Johnson Foundation and the Bill & Melinda Gates Foundation.